| Progression of medullary thyroid carcinoma: assessment with calcitonin and carcinoembryonic antigen doubling times A Laure Giraudet, A Al Ghulzan, A Aupérin, S Leboulleux, A Chehboun, ... European Journal of Endocrinology 158 (2), 239-246, 2008 | 304 | 2008 |
| Imaging medullary thyroid carcinoma with persistent elevated calcitonin levels AL Giraudet, D Vanel, S Leboulleux, A Aupérin, C Dromain, L Chami, ... The Journal of Clinical Endocrinology & Metabolism 92 (11), 4185-4190, 2007 | 294 | 2007 |
| Long-term follow-up of patients with papillary and follicular thyroid cancer: a prospective study on 715 patients M Brassard, I Borget, A Edet-Sanson, AL Giraudet, O Mundler, M Toubeau, ... The Journal of Clinical Endocrinology & Metabolism 96 (5), 1352-1359, 2011 | 260 | 2011 |
| Thyroidectomy without radioiodine in patients with low-risk thyroid cancer S Leboulleux, C Bournaud, CN Chougnet, S Zerdoud, A Al Ghuzlan, ... New England Journal of Medicine 386 (10), 923-932, 2022 | 137 | 2022 |
| Breast cancer recurrence diagnosis suspected on tumor marker rising: Value of whole‐body 18FDG‐PET/CT imaging and impact on patient management L Champion, E Brain, AL Giraudet, E Le Stanc, M Wartski, V Edeline, ... Cancer 117 (8), 1621-1629, 2011 | 116 | 2011 |
| Tyrosine kinase inhibitor treatments in patients with metastatic thyroid carcinomas: a retrospective study of the TUTHYREF network MH Massicotte, M Brassard, M Claude-Desroches, I Borget, F Bonichon, ... European journal of endocrinology 170 (4), 575-582, 2014 | 110 | 2014 |
| Association of peripheral multifocal choroiditis with sarcoidosis: A study of thirty‐seven patients S Abad, V Meyssonier, J Allali, H Gouya, AL Giraudet, D Monnet, C Parc, ... Arthritis Care & Research 51 (6), 974-982, 2004 | 76 | 2004 |
| Interest of systematic screening of pheochromocytoma in patients with neurofibromatosis type 1 L Képénékian, T Mognetti, JC Lifante, AL Giraudet, C Houzard, S Pinson, ... European Journal of Endocrinology 175 (4), 335-344, 2016 | 73 | 2016 |
| Assessment of response to endocrine therapy using FDG PET/CT in metastatic breast cancer: a pilot study N Mortazavi-Jehanno, AL Giraudet, L Champion, F Lerebours, E Le Stanc, ... European journal of nuclear medicine and molecular imaging 39, 450-460, 2012 | 67 | 2012 |
| Predictive factors of outcome in poorly differentiated thyroid carcinomas C de la Fouchardière, M Decaussin-Petrucci, J Berthiller, F Descotes, ... European Journal of Cancer 92, 40-47, 2018 | 65 | 2018 |
| Long-term efficacy of radionuclide therapy in patients with disseminated neuroendocrine tumors uncontrolled by conventional therapy C Nguyen, M Faraggi, AL Giraudet, C de Labriolle-Vaylet, T Aparicio, ... Journal of Nuclear Medicine 45 (10), 1660-1668, 2004 | 62 | 2004 |
| Radioactive iodine therapy, molecular imaging and serum biomarkers for differentiated thyroid cancer: 2017 guidelines of the French Societies of Nuclear Medicine, Endocrinology … S Zerdoud, AL Giraudet, S Leboulleux, L Leenhardt, S Bardet, J Clerc, ... Annales D'endocrinologie 78 (3), 162-175, 2017 | 61 | 2017 |
| TERT promoter mutations identify a high-risk group in metastasis-free advanced thyroid carcinoma C Bournaud, F Descotes, M Decaussin-Petrucci, J Berthiller, ... European Journal of Cancer 108, 41-49, 2019 | 58 | 2019 |
| A first-in-human study investigating biodistribution, safety and recommended dose of a new radiolabeled MAb targeting FZD10 in metastatic synovial sarcoma … AL Giraudet, PA Cassier, C Iwao-Fukukawa, G Garin, JN Badel, D Kryza, ... BMC cancer 18, 1-13, 2018 | 58 | 2018 |
| Single photon emission tomography/computed tomography (SPET/CT) and positron emission tomography/computed tomography (PET/CT) to image cancer JL Alberini, V Edeline, AL Giraudet, L Champion, B Paulmier, O Madar, ... Journal of surgical oncology 103 (6), 602-606, 2011 | 43 | 2011 |
| PSMA targeting in metastatic castration-resistant prostate cancer: where are we and where are we going? AL Giraudet, D Kryza, M Hofman, A Moreau, K Fizazi, A Flechon, RJ Hicks, ... Therapeutic Advances in Medical Oncology 13, 17588359211053898, 2021 | 35 | 2021 |
| 18F-FDG PET/CT imaging versus dynamic contrast-enhanced CT for staging and prognosis of inflammatory breast cancer L Champion, F Lerebours, P Cherel, V Edeline, AL Giraudet, M Wartski, ... European journal of nuclear medicine and molecular imaging 40, 1206-1213, 2013 | 35 | 2013 |
| 3D absorbed dose distribution estimated by Monte Carlo simulation in radionuclide therapy with a monoclonal antibody targeting synovial sarcoma D Sarrut, JN Badel, A Halty, G Garin, D Perol, P Cassier, JY Blay, D Kryza, ... EJNMMI physics 4, 1-16, 2017 | 24 | 2017 |
| Phase III study of 18F-PSMA-1007 versus 18F-fluorocholine PET/CT for localization of prostate cancer biochemical recurrence: a prospective, randomized, crossover multicenter study P Olivier, AL Giraudet, A Skanjeti, C Merlin, P Weinmann, I Rudolph, ... Journal of Nuclear Medicine 64 (4), 579-585, 2023 | 23 | 2023 |
| Survey by the French Medicine Agency (ANSM) of the imaging protocol, detection rate, and safety of 68Ga-PSMA-11 PET/CT in the biochemical recurrence of prostate cancer … YM Chevalme, L Boudali, M Gauthé, C Rousseau, A Skanjeti, C Merlin, ... European Journal of Nuclear Medicine and Molecular Imaging 48, 2935-2950, 2021 | 18 | 2021 |
